Goldman Sachs Group Inc Dyne Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,340,443 shares of DYN stock, worth $22.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,340,443

Previous 994,886 34.73%

Holding current value

$22.7 Million

Previous $10.4 Million 22.63%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$6.81 - $14.78 $2.35 Million - $5.11 Million	345,557 Added 34.73%	1,340,443 $12.8 Million
Q1 2025 May 09, 2025	BUY	$10.46 - $25.46 $3.83 Million - $9.32 Million	366,183 Added 58.24%	994,886 $10.4 Million
Q4 2024 Feb 11, 2025	SELL	$23.56 - $35.55 $984,360 - $1.49 Million	-41,781 Reduced 6.23%	628,703 $14.8 Million
Q3 2024 Nov 14, 2024	SELL	$31.94 - $47.04 $45.5 Million - $67 Million	-1,425,265 Reduced 68.01%	670,484 $24.1 Million
Q2 2024 Aug 13, 2024	BUY	$23.65 - $35.63 $10.3 Million - $15.5 Million	434,661 Added 26.17%	2,095,749 $74 Million
Q1 2024 May 15, 2024	BUY	$13.06 - $29.18 $6.53 Million - $14.6 Million	500,316 Added 43.1%	1,661,088 $47.2 Million
Q4 2023 Feb 13, 2024	SELL	$6.62 - $13.64 $2.3 Million - $4.74 Million	-347,370 Reduced 23.03%	1,160,772 $15.4 Million
Q3 2023 May 14, 2024	BUY	$8.6 - $12.18 $2.99 Million - $4.23 Million	347,370 Added 29.93%	1,508,142 $13.5 Million
Q3 2023 Nov 14, 2023	SELL	$8.6 - $12.18 $4.31 Million - $6.11 Million	-501,387 Reduced 24.95%	1,508,142 $13.5 Million
Q2 2023 May 14, 2024	BUY	$8.53 - $14.28 $4.39 Million - $7.36 Million	515,079 Added 34.47%	2,009,529 $22.6 Million
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $4.39 Million - $7.36 Million	515,079 Added 34.47%	2,009,529 $22.6 Million
Q1 2023 May 14, 2024	BUY	$10.88 - $15.0 $7.16 Million - $9.88 Million	658,433 Added 78.76%	1,494,450 $17.2 Million
Q1 2023 May 11, 2023	BUY	$10.88 - $15.0 $7.16 Million - $9.88 Million	658,433 Added 78.76%	1,494,450 $17.2 Million
Q4 2022 May 14, 2024	BUY	$9.37 - $13.8 $4.11 Million - $6.05 Million	438,447 Added 110.28%	836,017 $9.69 Million
Q4 2022 Feb 13, 2023	BUY	$9.37 - $13.8 $4.11 Million - $6.05 Million	438,447 Added 110.28%	836,017 $9.69 Million
Q3 2022 May 14, 2024	BUY	$7.2 - $15.17 $2.39 Million - $5.03 Million	331,527 Added 501.99%	397,570 $5.05 Million
Q3 2022 Nov 10, 2022	BUY	$7.2 - $15.17 $2.39 Million - $5.03 Million	331,527 Added 501.99%	397,570 $5.05 Million
Q2 2022 May 14, 2024	SELL	$4.36 - $10.5 $4.77 Million - $11.5 Million	-1,094,729 Reduced 94.31%	66,043 $454,000
Q2 2022 Aug 15, 2022	SELL	$4.36 - $10.5 $54,561 - $131,397	-12,514 Reduced 15.93%	66,043 $454,000
Q1 2022 May 16, 2022	SELL	$6.52 - $12.27 $39,517 - $74,368	-6,061 Reduced 7.16%	78,557 $757,000
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $539,199 - $728,758	45,349 Added 115.48%	84,618 $1.01 Million
Q3 2021 Nov 10, 2021	BUY	$15.6 - $21.46 $612,596 - $842,712	39,269 New	39,269 $637,000

Others Institutions Holding DYN

# of Institutions

213

Shares Held

122M

Call Options Held

36.5K

Put Options Held

74.3K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $878M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Dyne Therapeutics, Inc. Transaction History